DRUG · Mapped RxNorm record
Cabozantinib
Normalized identity: cabozantinibView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
NCT04631744
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedCabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
CabozantinibDRUG · verified · RxNorm: cabozantinib
Sponsors & collaborators
Weill Medical College of Cornell Universitylead sponsor
Exelixiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04631744 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.